A Study Evaluating the Safety and Efficacy of Lovo-cel in Severe Sickle Cell Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Anjulika Chawla, MD, FAAP
bluebird bio, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Birmingham, Alabama, United States
- Facility name not stated
Oakland, California, United States
- Facility name not stated
Atlanta, Georgia, United States
- Facility name not stated
Chicago, Illinois, United States
- Facility name not stated
Bethesda, Maryland, United States
- Facility name not stated
Hackensack, New Jersey, United States
- Facility name not stated
New Hyde Park, New York, United States
- Facility name not stated
New York, New York, United States
- Facility name not stated
Chapel Hill, North Carolina, United States
- Facility name not stated
Philadelphia, Pennsylvania, United States
- Facility name not stated
Charleston, South Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 2 Feb 2015
- Primary completion
- 31 Jul 2023
- Completion
- 30 Jan 2024
- Last update posted
- 14 Mar 2025
- Registered enrollment
- 54
- Registry id
- NCT02140554
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.